Historic Cash & Equivalents for Nuvation Bio (NUVB) over the last 4 years, with Jun 2025 value amounting to $248.0 million.
- Nuvation Bio's Cash & Equivalents rose 623.26% to $248.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $248.0 million, marking a year-over-year increase of 623.26%. This contributed to the annual value of $35.7 million for FY2024, which is 16.24% down from last year.
- Per Nuvation Bio's latest filing, its Cash & Equivalents stood at $248.0 million for Q2 2025, which was up 416.85% from $48.0 million recorded in Q1 2025.
- Nuvation Bio's 5-year Cash & Equivalents high stood at $638.9 million for Q1 2021, and its period low was $24.4 million during Q3 2023.
- In the last 3 years, Nuvation Bio's Cash & Equivalents had a median value of $34.4 million in 2024 and averaged $62.4 million.
- As far as peak fluctuations go, Nuvation Bio's Cash & Equivalents surged by 25,529.22% in 2021, and later plummeted by 83.38% in 2022.
- Over the past 5 years, Nuvation Bio's Cash & Equivalents (Quarterly) stood at $344.6 million in 2021, then tumbled by 59.76% to $138.7 million in 2022, then tumbled by 82.41% to $24.4 million in 2023, then increased by 23.12% to $30.0 million in 2024, then spiked by 623.26% to $248.0 million in 2025.
- Its last three reported values are $248.0 million in Q2 2025, $48.0 million for Q1 2025, and $30.0 million during Q3 2024.
